Skip to content
10-K

Annual Report

ENTEROLOGICS, INC.

0001477932-13-001446

← back to feed
Filed
Mar 29, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 28, 2013 37.16M sh
Capex FY 2012 · Dec 31, 2012 $300K
Capex FY 2012 · Dec 31, 2011 $300K
Operating Cash Flow FY 2012 · Dec 31, 2012 −$199.98K
Operating Cash Flow FY 2012 · Dec 31, 2012 −$451.99K
Operating Cash Flow FY 2012 · Dec 31, 2011 −$193.94K
Stockholders Equity FY 2012 · Dec 31, 2012 −$352.99K
Stockholders Equity FY 2012 · Dec 31, 2011 $362.47K
Stockholders Equity FY 2012 · Dec 31, 2010 −$20.52K
Stockholders Equity FY 2012 · Dec 31, 2009 $40.01K
Current Liabilities FY 2012 · Dec 31, 2012 $376.35K
Current Liabilities FY 2012 · Dec 31, 2011 $166.2K
Total Liabilities FY 2012 · Dec 31, 2012 $443.02K
Total Liabilities restated FY 2012 · Dec 31, 2011 $182.86K
Total Assets FY 2012 · Dec 31, 2012 $90.03K
Total Assets FY 2012 · Dec 31, 2011 $595.33K
Sga Expense FY 2012 · Dec 31, 2012 $26.55K
Sga Expense FY 2012 · Dec 31, 2012 $89.25K
Sga Expense restated FY 2012 · Dec 31, 2011 $37.37K
Rd Expense FY 2012 · Dec 31, 2012 $112.48K
Rd Expense FY 2012 · Dec 31, 2012 $203.82K
Rd Expense FY 2012 · Dec 31, 2011 $91.34K
Net Income FY 2012 · Dec 31, 2012 −$932.95K
Net Income FY 2012 · Dec 31, 2012 −$1.24M
Net Income FY 2012 · Dec 31, 2011 −$223.01K
Net Income FY 2012 · Dec 31, 2010 −$72.61K
Net Income FY 2012 · Dec 31, 2009 −$8.1K
Cost Of Revenue FY 2012 · Dec 31, 2012 −$451.6K
Cost Of Revenue FY 2012 · Dec 31, 2011 −$234.54K
Current Assets FY 2012 · Dec 31, 2011 $17.98K